By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933



Company News
Catalyst Pharmaceuticals (CPRX) Provides An Update Of 2015 Goals For Its Product Portfolio 1/12/2015 7:23:52 AM
Catalyst Pharmaceuticals (CPRX) Appoints David D. Muth, Executive Vice President, Chief Commercial Officer 1/5/2015 7:15:10 AM
Catalyst Pharmaceuticals (CPRX) Announces The Passing Of Hubert E. Huckel, Co-Founder And Director 12/17/2014 7:46:57 AM
Catalyst Pharmaceuticals (CPRX) To Present At The Piper Jaffray 26th Annual Healthcare Conference 12/1/2014 3:10:18 PM
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of U.S. Patent Application For The Reduction Or Elimination Of Visual Field Defects By Treating Patients With CPP-115 11/24/2014 1:13:45 PM
Catalyst Pharmaceuticals (CPRX) CEO Outlines Biotech's 5 Phases Of Risk 11/24/2014 4:28:54 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Third Quarter 2014 Financial Results 11/14/2014 7:53:13 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Proposed Settlement Of Pending Securities Class Action Lawsuit 11/4/2014 7:25:32 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Appoints David J. Caponera As Vice President Patient Advocacy And Reimbursement 10/28/2014 7:13:30 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) To Present Firdapse Phase 3 Trial Results At The 61st Annual Meeting Of The American Association Of Neuromuscular And Electrodiagnostic Medicine 10/27/2014 7:33:40 AM